Martin Shkreli resigns as CEO of Turing Pharmaceuticals
Following his arrest on securities fraud charges, Martin Shkreli has resigned as chief executive of Turing Pharmaceuticals. Turing, a privately-held biopharmaceutical company, announced Shkreli’s resignation today and the appointment of Ron Tilles to the position of interim chief executive officer. Tilles will continue to serve as chairman of the Board of Directors. He said, “We…